Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart Failure

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Circulation

• Publication date

  2007-09-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.106.655076PMID 17698733
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acute coronary syndrome vs nonspecific troponin elevation: clinical predictors and survival analysis.

  2007cited by this paper
• Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction

  2007cited by this paper
• Prevalence and Determinants of Troponin T Elevation in the General Population

  2006influential reference
• Multiple biomarkers for the prediction of first major cardiovascular events and death.

  2006cited by this paper
• Confidence Intervals for Rank Statistics: Somers’ D and Extensions

  2006cited by this paper
• Intraindividual variation of amino-terminal pro-B-type natriuretic peptide levels in patients with stable heart failure.

  2006cited by this paper
• Cardiac troponins and chronic kidney disease.

  2006cited by this paper
• Cardiac troponins and chronic kidney disease.

  2006cited by this paper
• Incremental prognostic value of changes in B-type natriuretic peptide in heart failure.

  2006cited by this paper
• Narrative Review: Alternative Causes for Elevated Cardiac Troponin Levels when Acute Coronary Syndromes Are Excluded

  2005cited by this paper
• Prognostic value of cardiac troponin T in patients with both acute and chronic stable congestive heart failure: comparison with atrial natriuretic peptide, brain natriuretic peptide and plasma norepinephrine.

  2005cited by this paper
• Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors

  2005cited by this paper
• Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome.

  2005cited by this paper
• N-Terminal–Pro-Brain Natriuretic Peptide Predicts Outcome After Hospital Discharge in Heart Failure Patients

  2004cited by this paper
• High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure.

  2004cited by this paper
• Ongoing Myocardial Injury in Stable Severe Heart Failure: Value of Cardiac Troponin T Monitoring for High-Risk Patient Identification

  2004cited by this paper
• Serial measure of cardiac troponin T levels for prediction of clinical events in decompensated heart failure.

  2004cited by this paper
• The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT.

  2004cited by this paper
• Cardiac Troponin I Is Associated With Impaired Hemodynamics, Progressive Left Ventricular Dysfunction, and Increased Mortality Rates in Advanced Heart Failure

  2003cited by this paper
• Prognostic value of combination of cardiac troponin T and B-type natriuretic peptide after initiation of treatment in patients with chronic heart failure.

  2003cited by this paper
• Prognostic use of cardiac troponin T and troponin I in patients with heart failure.

  2003cited by this paper
• Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure.

  2003cited by this paper
• Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure.

  2002cited by this paper
• Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes: Simultaneous Assessment of Troponin I, C-Reactive Protein, and B-Type Natriuretic Peptide

  2002cited by this paper
• Use of cytosolic and myofibril markers in the detection of ongoing myocardial damage in patients with chronic heart failure.

  2002cited by this paper
• Literature alert

  2002cited by this paper
• Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction.

  2002cited by this paper
• Serum cardiac troponin T and plasma brain natriuretic peptide in patients with cardiac decompensation

  2002cited by this paper
• Persistently Increased Serum Concentrations of Cardiac Troponin T in Patients With Idiopathic Dilated Cardiomyopathy Are Predictive of Adverse Outcomes

  2001cited by this paper
• A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.

  2001cited by this paper
• Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.

  2000cited by this paper
• Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

  2000cited by this paper
• CARDIAC-SPECIFIC TROPONIN I LEVELS TO PREDICT THE RISK OF MORTALITY IN PATIENTS WITH ACUTE CORONARY SYNDROMES

  2000cited by this paper
• Ingenuous interpretation of elevated blood levels of macromolecular markers of myocardial injury: a recipe for confusion.

  2000cited by this paper
• Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker

  2000cited by this paper
• Cardiac troponin I as diagnostic and prognostic marker in severe heart failure.

  2000cited by this paper
• Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

  2000cited by this paper
• Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy.

  1999cited by this paper
• A novel biochemical approach to congestive heart failure: cardiac troponin T.

  1999cited by this paper
• Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure.

  1999cited by this paper
• Cardiac troponins: IT upgrade for the heart.

  1998cited by this paper
• Circulating cardiac troponin I in severe congestive heart failure.

  1997cited by this paper
• Apoptosis in the failing human heart.

  1997cited by this paper
• Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes.

  1996cited by this paper
• Chronic nonocclusive coronary artery constriction impairs ventricular function, myocardial structure, and cardiac contractile protein enzyme activity in rats.

  1992cited by this paper
• Statistical methods for assessing agreement between two methods of clinical measurement.

  1986cited by this paper

• Research progress on multi-marker detection technology for cardiovascular diseases (review)

  2026cites this paper
• Sex‐Specific Cardiovascular Consequences of Long‐Term High‐Salt Diet in Mice

  2025cites this paper
• Construction and validation of a prediction model for 90-day readmission risk in patients with chronic heart failure

  2025cites this paper
• Impact of High-Sensitivity Cardiac Troponin T on Clinical Outcomes in Patients With Cardiac Sarcoidosis.

  2025cites this paper
• Does coronary microvascular dysfunction play a role in heart failure with reduced ejection fraction?

  2025cites this paper
• Associations of cardiac biomarkers with chronic kidney disease and mortality in US individuals without prevalent cardiovascular disease

  2025cites this paper
• Adhered macrophages as an additional marker of cardiomyocyte injury in biopsies of patients with dilated cardiomyopathy

  2025cites this paper
• Innovative Approaches in the Early Detection of Heart Failure

  2025cites this paper
• Professor Alan H.B. Wu: Contributions that will stand the test of time.

  2025cites this paper
• The Prognostic Value of Troponin Levels Adjusted for Renal Function in Heart Failure – A Systematic Review

  2025cites this paper
• Prognostication in emergency room patients: comparing ultrasensitive and contemporary quantification of cardiac troponin levels below the 99th percentile

  2025cites this paper
• New Frontiers of microRNA in Heart Failure: From Clinical Risk to Therapeutic Applications

  2025cites this paper
• Novel insights into short-term troponin remeasurement and long-term cardiac function and structure following fulminant myocarditis

  2025cites this paper
• Beyond Acute Coronary Syndromes: Troponins as Diagnostic and Prognostic Tools in Heart Failure

  2025cites this paper
• Cardiac troponins and coronary artery calcium score: a systematic review

  2024cites this paper
• RV in COPD – The complicated matters of the heart – Correlation of ECHO and biomarker with COPD severity and outcome

  2024cites this paper
• Prognostic relationship between high sensitivity troponin I level, hematoma volume and glasgow coma score in patients diagnosed with spontaneous intracerebral hemorrhage

  2024cites this paper
• Associations Between Biomarkers of Myocardial Injury and Systemic Inflammation and Risk of Incident Ventricular Arrhythmia.

  2024cites this paper
• The Role of High-Sensitivity Troponin T Regarding Prognosis and Cardiovascular Outcome across Heart Failure Spectrum

  2024cites this paper
• Plasma and serum volume remain unchanged following a 12-h fast from food and drink despite changes in blood and urinary hydration markers

  2024cites this paper
• High-sensitivity cardiac troponin T and N-terminal b-type natriuretic propeptide are associated with cardiac and all-cause mortality in older adults - A population-based ten-year follow-up study.

  2024cites this paper
• Association of high-sensitivity troponin T with left ventricular dysfunction in prediabetes

  2024cites this paper
• Clinical impact of circulating biomarkers in prediction of adverse cardiac events in patients with congenital heart disease. A systematic review.

  2024cites this paper
• Diagnostic accuracy of baseline troponin and troponin change for the diagnosis of myocardial infarction complicated with heart failure

  2024cites this paper
• Exercise training and high‐sensitivity cardiac troponin‐I in patients with heart failure with reduced ejection fraction

  2024influential citation
• Heart Failure with Mildly Reduced Ejection Fraction—A Phenotype Waiting to Be Explored

  2024cites this paper
• Beyond Natriuretic Peptides: Unveiling the Power of Emerging Biomarkers in Heart Failure

  2024cites this paper
• Multiorgan Dysfunction and Associated Prognosis in Transthyretin Cardiac Amyloidosis

  2024cites this paper
• New reference limits for cardiac troponin T and N-terminal b-type natriuretic propeptide in elders.

  2024cites this paper
• Cardiac Troponin and Treatment Effects of Omecamtiv Mecarbil: Results from the GALACTIC-HF study.

  2024cites this paper
• Clinical Interpretation of Serum Troponin in the Era of High-Sensitivity Testing

  2024cites this paper
• Cardiac Troponin T and NT-proBNP for Prediction of 30-Day Readmission or Death in Patients with Acute Dyspnea: Data from the Akershus Cardiac Examination 2 Study

  2023cites this paper
• Do Heart Failure Biomarkers Influence Heart Failure Treatment Response?

  2023cites this paper
• Relationship Between Albumin-Corrected Anion Gap and Mortality in Hospitalized Heart Failure Patients

  2023cites this paper
• Multi-proteomic Biomarker Risk Scores for Predicting Risk and Guiding Therapy in Patients with Coronary Artery Disease

  2023cites this paper
• Establishing optimal cutoff values for high-sensitivity cardiac troponin algorithms in risk stratification of acute myocardial infarction

  2023cites this paper
• Different expression and prognostic value of troponin in ischemic cardiomyopathy and non-ischemic dilated cardiomyopathy

  2023cites this paper
• Assessment of Biomarkers of Myocardial injury, Inflammation, and Renal Function in Heart Failure with Reduced Ejection Fraction: The VICTORIA Biomarker Substudy.

  2023cites this paper
• N-Terminal Pro-Bnp (NT-ProBNP) and high sensitive troponin levels in patients with ischemic dilated cardiomyopathy and idiopathic dilated cardiomyopathy

  2023cites this paper
• Cardiac Biomarkers

  2023cites this paper
• V5 and High Sensitivity Cardiac Troponin T for Early Detection of Cardiac Toxicity During Left Breast Cancer Irradiation.

  2023cites this paper
• A prognostic model based on clinical biomarkers for heart failure in adult patients following allogeneic hematopoietic stem cell transplantation.

  2023cites this paper
• What Is the Clinical Utility of Cardiac Troponins in Heart Failure? Are They Modifiable Beyond Their Prognostic Value?

  2023cites this paper
• Correlation of Mean Heart Dose and Cardiac Biomarkers with Electrocardiographic Changes in Patients Receiving Thoracic Radiation Therapy

  2023cites this paper
• Antiretroviral therapy and HIV‐associated cardiovascular disease: a prospective cardiac biomarker and CMR tissue characterization study

  2023cites this paper
• Prospective Analysis of Immunosuppressive Therapy in Cardiac Sarcoidosis With Fluorodeoxyglucose Myocardial Accumulation: PRESTIGE Study.

  2023cites this paper
• Comparisons of multiple troponin assays for detecting chronic myocardial injury in the general population: redundant or complementary?

  2023cites this paper
• Heart Failure

  2022cites this paper
• Ultra-high sensitivity cardiac troponin-I concentration and left ventricular structure and function in women with ischemia and no obstructive coronary artery disease

  2022cites this paper
• New Biomarkers and Their Potential Role in Heart Failure Treatment Optimisation—An African Perspective

  2022cites this paper
• The effect of the immunoassay curve fitting routine on bias in troponin

  2022cites this paper
• The relationship between infarct volume and high sensitivity troponin I level in patients diagnosed with ischemic stroke

  2022cites this paper
• Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future

  2022cites this paper
• Prognostic value of high‐sensitivity cardiac troponin I in patients with non‐ischaemic heart failure: insights from China

  2022cites this paper
• Associations between obstructive sleep apnea and cardiac troponin T levels: a meta-analysis

  2022cites this paper
• Associations between elevated high-sensitive cardiac troponin t and outcomes in patients with acute abdominal pain

  2022cites this paper
• Role of biomarkers in the heart failure clinic

  2022cites this paper
• Troponin is unrelated to outcomes in heart failure patients discharged from the emergency department

  2022cites this paper
• The Prognostic Value of Anemia in Patients with Preserved, Mildly Reduced and Recovered Ejection Fraction

  2022cites this paper
• Cardiac remodelling – Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology

  2022cites this paper
• Heart failure with mildly reduced ejection fraction: emerging frontiers in clinical characteristics, prognosis, and treatment.

  2022cites this paper
• Utility of Cardiac Troponins in Patients With Chronic Kidney Disease

  2022cites this paper
• Changes in cardiac biomarkers in association with alterations in cardiac structure and function, and health status in heart failure with reduced ejection fraction: the EVALUATE‐HF trial

  2022cites this paper
• Gut microbiota-generated metabolite, trimethylamine-N-oxide, and subclinical myocardial damage: a multicenter study from Thailand

  2021cites this paper
• The predictive value of high-sensitive troponin I for perioperative risk in patients undergoing gastrointestinal tumor surgery

  2021cites this paper
• Primera declaración Mexicana en materia de Insuficiencia Cardiaca

  2021cites this paper
• In Search of the Lost Ark: Will Troponin Help in Finding Effective Treatments for HFpEF?

  2021cites this paper
• Troponin: an important prognostic biomarker in patients with heart failure and reduced ejection fraction?

  2021cites this paper
• Inpatient versus outpatient intravenous diuresis for the acute exacerbation of chronic heart failure

  2021cites this paper
• Heart failure risk estimation based on novel biomarkers

  2021cites this paper
• Traditional and Emerging Biomarkers in Asymptomatic Left Ventricular Dysfunction—Promising Non-Coding RNAs and Exosomes as Biomarkers in Early Phases of Cardiac Damage

  2021cites this paper
• The prognostic impact of the serum heart-type fatty acid-binding protein level in patients with sepsis who were admitted to the non-surgical intensive-care unit

  2021cites this paper
• Novel molecular markers of cardiovascular disease risk in type 2 diabetes mellitus.

  2021cites this paper
• Biomarkers for the diagnosis and management of heart failure

  2021cites this paper
• Diagnostic Value of High-Sensitivity Troponin T for Subclinical Left Ventricular Systolic Dysfunction in Patients with Sepsis

  2021cites this paper
• Concentration‐dependent clinical and prognostic importance of high‐sensitivity cardiac troponin T in heart failure and a reduced ejection fraction and the influence of empagliflozin: the EMPEROR‐Reduced trial

  2021cites this paper
• A Test in Context: Interpretation of High-Sensitivity Cardiac Troponin Assays in Different Clinical Settings.

  2021cites this paper
• A systematic review of biomarkers in Takotsubo syndrome: A focus on better understanding the pathophysiology

  2021cites this paper
• Biomarkers in Heart Failure: Clinical Insights.

  2021cites this paper
• Impact of cellular myocardial infiltration on clinical outcome in non-ischaemic heart failure

  2021cites this paper
• Integration of imaging and circulating biomarkers in heart failure: a consensus document by the Biomarkers and Imaging Study Groups of the Heart Failure Association of the European Society of Cardiology

  2021cites this paper
• Why Do We Not Assess Sympathetic Nervous System Activity in Heart Failure Management: Might GRK2 Serve as a New Biomarker?

  2021cites this paper
• Neurohumoral, cardiac and inflammatory markers in the evaluation of heart failure severity and progression

  2021cites this paper
• Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation

  2021cites this paper
• Biomarkers in the management of acute heart failure: state of the art and role in COVID‐19 era

  2021cites this paper
• Serial Assessment of High-Sensitivity Cardiac Troponin and the Effect of Dapagliflozin in Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of the DAPA-HF Trial

  2021cites this paper
• Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC)

  2021cites this paper
• Biomarkers and Precision Medicine in Heart Failure

  2020cites this paper
• Release of high-sensitive TROPonin T by implantation of an entirely subcutaneous Implantable Cardioverter-defibrillator compared to a conventional transvenous approach: the TROPIC registry

  2020cites this paper
• Reference interval and the role of soluble suppression of tumorigenicity 2 (sST2) in subclinical cardiac dysfunction at health checkups

  2020cites this paper
• Evaluating the Diagnostic and Prognostic Value of Biomarkers for Heart Disease and Major Adverse Cardiac Events in Patients With Muscular Dystrophy.

  2020cites this paper
• Preoperative right ventricular strain predicts sustained right ventricular dysfunction after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension

  2020cites this paper
• Consenso de expertos sobre la insuficiencia cardiaca con fracción de eyección reducida: más allá de las guías

  2020cites this paper
• Real-Life Multimarker Monitoring in Patients with Heart Failure: Continuous Remote Monitoring of Mobility and Patient-Reported Outcomes as Digital End Points in Future Heart-Failure Trials

  2020cites this paper
• Significance of NT-proBNP and High-Sensitivity Troponin in Friedreich Ataxia

  2020cites this paper
• Highly Sensitive Cardiac Troponin T Changes and Its Prognostic Value in Patients with Acute Stroke

  2020cites this paper
• Impact of combined baseline and postprocedural troponin values on clinical outcome following the MitraClip procedure

  2020cites this paper
• ACE inhibitörü /ARB, Beta-bloker ve MRA ile stabil seyreden NYHA II kalp yetersizliği olgularında sakubitril/valsartan’a geçilmeli mi?

  2020cites this paper
• Biomarkers in atrial fibrillation and heart failure with non-reduced ejection fraction: Diagnostic application and new cut-off points.

  2020cites this paper
• High‐sensitivity cardiac troponin T 30 days all‐come mortality in patients with acute heart failure. A Propensity Score‐Matching Analysis Based on the EAHFE Registry. TROPICA4 Study

  2020cites this paper